Ruminant-produced trans-fatty acids raise plasma total and small HDL particle concentrations in male Hartley guinea pigs

Journal of Nutrition

Volumn 140, Issue 12, 2010, Pages 2173-2179

  Rice, Beth H ^a   Kraft, Jana ^a   Destaillats, Frédéric ^b   Bauman, Dale E ^c   Lock, Adam L ^a,d  

^a UNIVERSITY OF VERMONT   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c Department of Obstetrics Gynecology   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COCONUT OIL; HIGH DENSITY LIPOPROTEIN; HYDROGENATED VEGETABLE OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN OIL; TRANS FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BUTTER; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEEDING; GUINEA PIG; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; RISK ASSESSMENT;

ANIMALS; FATTY ACIDS; GUINEA PIGS; LIPOPROTEINS, HDL; MALE; PARTICLE SIZE; RISK FACTORS; RUMINANTS;

CAVIA; GLYCINE MAX;

EID: 78649615677     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.127258     Document Type: Article

References (43)

1. Mirzaei M, Truswell AS, Taylor R, Leeder SR. Coronary heart disease epidemics: not all the same. Heart. 2009;95:740-6.
2. Stender S, Astrup A, Dyerberg J. Ruminant and industrially produced trans-fatty acids: health aspects. Food Nutr Res. 2008;52:10.3402/fnr. v52i0.1651.
3. Lock AL, Parodi P, Bauman DE. The biology of trans-fatty acids: implications for human health and the dairy industry. Aust J Dairy Technol. 2005;60:134-42.
4. Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL. Intake of ruminant trans-fatty acids and risk of coronary heart disease. Int J Epidemiol. 2008;37:173-82.
5. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659-69.
6. Mozaffarian D, Willett WC. Trans-fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep. 2007;9:486-93.
7. Mensink RP, Katan MB. Effect of dietary trans-fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323:439-45.
8. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, et al. Do transfatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans-Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87:558-66.
9. Stender S, Dyerberg J. Influence of trans-fatty acids on health. Ann Nutr Metab. 2004;48:61-6.
10. United States FDA. Food labeling: trans-fatty acids in nutrition labeling, nutrient content claims, and health claims. Fed Regist. 2003;68:41433-506.
11. Fernandez ML, Lin EC, McNamara DJ. Regulation of guinea pig plasma low-density lipoprotein kinetics by dietary fat saturation. J Lipid Res. 1992;33:97-109.
12. Fernandez ML. Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr. 2001;131:10-20.
13. Chardigny JM, Malpuech-Brugere C, Dionisi F, Bauman DE, German B, Mensink RP, Combe N, Chaumont P, Barbano DM, et al. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans-fatty acids on cardiovascular risk factors in humans. Contemp Clin Trials. 2006;27:364-73.
14. Cos E, Ramjiganesh T, Roy S, Yoganathan S, Nicolosi RJ, Fernandez ML. Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension. Lipids. 2001;36:1209-16.
15. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC. trans-Fatty acids and systemic inflammation in heart failure. Am J Clin Nutr. 2004;80:1521-5.
16. Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab. 2002;48:171-80.
17. El Harchaoui K, Arsenault BJ, Franssen R, Despres JP, Hovingh GK, Stroes ES, Otvos JD, Wareham NJ, Kastelein JJ, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150:84-93.
18. Ip S, Lichtenstein AH, Chung M, Lau J, Balk EM. Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med. 2009;150:474-84.
19. Torres-Gonzalez M, Leite JO, Volek JS, Contois JH, Fernandez ML. Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs. J Nutr Biochem. 2008;19:856-63.
20. Torres-Gonzalez M, Volek JS, Leite JO, Fraser H, Luz Fernandez M. Carbohydrate restriction reduces lipids and inflammation and prevents atherosclerosis in Guinea pigs. J Atheroscler Thromb. 2008;15:235-43.
21. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-7.
22. Carr TP, Andresen CJ, Rudel LL. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem. 1993;26:39-42.
23. Wadsworth MP, Sobel BE, Schneider DJ, Tra W, van Hirtum H, Taatjes DJ. Quantitative analysis of atherosclerotic lesion composition in mice. Methods Mol Biol. 2006;319:137-52.
24. Lin EC, Fernandez ML, McNamara DJ. Dietary fat type and cholesterol quantity interact to affect cholesterol metabolism in guinea pigs. J Nutr. 1992;122:2019-29.
25. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119:902-7.
26. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med. 1999;340:1933-40.
27. Sharman MJ, Fernandez ML, Zern TL, Torres-Gonzalez M, Kraemer WJ, Volek JS. Replacing dietary carbohydrate with protein and fat decreases the concentrations of small LDL and the inflammatory response induced by atherogenic diets in the guinea pig. J Nutr Biochem. 2008;19:732-8.
28. Lin EC, Fernandez ML, Tosca MA, McNamara DJ. Regulation of hepatic LDL metabolism in the guinea pig by dietary fat and cholesterol. J Lipid Res. 1994;35:446-57.
29. Tyburczy C, Major C, Lock AL, Destaillats F, Lawrence P, Brenna JT, Salter AM, Bauman DE. Individual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters. J Nutr. 2009;139:257-63.
30. Meijer GW, van Tol A, van Berkel TJ, Weststrate JA. Effect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster. Atherosclerosis. 2001;157:31-40.
31. Esmaillzadeh A, Azadbakht L. Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am J Clin Nutr. 2008;88:913-21.
32. Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 2006;113:1556-63.
33. Shoji T, Hatsuda S, Tsuchikura S, Shinohara K, Kimoto E, Koyama H, Emoto M, Nishizawa Y. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis. Atherosclerosis. 2009;202: 582-8.
34. Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC Jr, O'Leary DH, Saad MF, Tsai MY, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2007;192:211-7.
35. Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, Siscovick D, Freedman DS, Kronmal R. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol. 2002;22:1175-80.
36. El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, et al. Value of low- density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007; 49:547-53.
37. St-Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM, Despres JP, Lamarche B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25: 553-9.
38. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-41.
39. Kontush A, Chapman MJ. Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med. 2006;3:144-53.
40. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans-fatty acids and systemic inflammation in women. Am J Clin Nutr. 2004;79:606-12.
41. Craig-Schmidt MC. World-wide consumption of trans-fatty acids. Atherosclerosis Suppl. 2006;7:1-4.
42. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C, Lamarche B. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr. 2003;78:370-5.
43. Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B. Study of the effect of trans-fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr. 2008;87:593-9.